Publications

Bylsma LC, Gulbech Ording A, Froslev T, Mehnert F, Fryzek J, Morales Arias J, Roth A, Sorensen HT, Berentsen S. Occurrence, survival, and thromboembolic risk in cold agglutinin disease: a population-based cohort analysis. Presented at the 23rd Congress of the European Hematology Association, June 14-17 2018, Stockholm, Sweden.

Ruzin A, Pastula ST, Levin-Sparenberg E, Jiang X, Fryzek J, Tovchigrechko A, Lu B, Qi Y, Liu H, Jin H, Yu L, Hackett J, Villafana T, Esser MT. 2018. Characterization of circulating RSV strains among subjects in the OUTSMART-RSV surveillance program during the 2016-17 winter viral season in the United States. PLoS One 13(7):e0200319.

Bylsma LC, Gulbech Ording A, Froslev T, Mehnert F, Fryzek JP, Morales Arias J, Roth A, Sorensen HT, Berentsen S. Occurrence, survival, and thromboembolic risk in cold agglutinin disease: a population-based cohort analysis. Presented at the 23rd Congress of the European Hematology Association, June 14-17 2018, Stockholm, Sweden.

Beebe-Dimmer JL, Ruterbusch JJ, Bylsma LC, Gillezeau C, Fryzek J, Schultz NM, Flanders SC, Barlev A, Heath E, Quek RGW. 2018. Patterns of bicalutamide use in prostate cancer treatment: A U.S. real-world analysis using the SEER-Medicare database. Adv Ther 35(1):1438-1451.

Hooda N, McFarlane T, Pasetka M, DeAngelis C. 2018. Investigating guideline-consistent anti-emetic prescribing practices at the Odette Cancer Centre (OCC). Poster for oral presentation seminar, “Meet the Future Leaders in Research,” at the Ontario Pharmacist Conference, Huntsville, ON, June 2018.

Schwartz KL, Simon MS, Bylsma LC, Ruterbusch JJ, Beebe-Dimmer JL, Schultz NM,  Flanders SC, Barlev A, Fryzek JP, Quek RGW. 2018. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States. Cancer 124(10):2104-2114.

Czerkies L, Kineman B, Cohen S, Reichert H, Carvalho R. A pooled analysis of growth and tolerance of infants exclusively fed a partially hydrolyzed whey or intact protein-based infant formulas. Presented at the 5th International Conference on Nutrition and Growth, March 1-3, 2018, Paris, France.

Bylsma LC, Gillezeau C, Garawin T, Kelsh M, Fryzek J, Sangare L, Lowe KA. Prevalence of RAS and BRAF Mutations in Metastatic Colorectal Cancer (mCRC) Patients by Tumor Location. Presented at the Gastrointestinal Cancers Symposium, January 18-20, 2018, San Francisco, CA.

Fryzek JP, Reichert H, Summers N, Townes L, Deuson R, Alexander DD, Vanderpuye-Orgle J. 2018. Indirect treatment comparison of cabazitaxel for patients with metastatic castrate-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen. PLoS One 13(4):e0195790.

Reichert H, Fryzek J, Bylsma LC. Survival synthesis: methods for meta-analysis of survival rates and aggregation of survival data. Presented at the 12th International Conference on Health Policy Statistics, January 10-12, 2018, Charleston, SC.